Test Price
1,400 AED✅ Home Collection Available
RB1 Gene Deletion & Duplication Detection (Retinoblastoma) Test in UAE | 1400 AED
Executive Summary & Core Metrics
✅ Accuracy Guarantee
99.9% Diagnostic Sensitivity via ISO‑accredited MLPA processing.
🚚 Premium Logistics
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
📞 Clinical Guidance
Complimentary telephonic post‑test clinical interpretation by a DHA‑licensed genetic counsellor.
💳 Insurance Support
Direct billing verification via WhatsApp: +971 54 548 8731
Test Overview & Methodology
RB1 Gene Deletion & Duplication Detection is a molecular genetic assay that identifies large genomic rearrangements in the RB1 gene, the primary cause of heritable retinoblastoma. It is ordered by oncologists, paediatric ophthalmologists, and clinical geneticists to confirm a diagnosis or assess familial risk in asymptomatic carriers.
| Feature | Our Test (MLPA) | Whole Gene Sequencing |
|---|---|---|
| Detection Sensitivity | >99% for exonic deletions/duplications | ~95% for all variant types (requires confirmation) |
| Turnaround Time | 7–10 working days | 3–4 weeks |
| Methodology | Multiplex Ligation‑dependent Probe Amplification (MLPA) | Next‑Generation Sequencing (NGS) + MLPA for CNVs |
| ISO 9001:2015 Accreditation | ✔️ (Cert: INT/EGQ/2509DA/3139) | Variable |
| Price | 1400 AED | ~2500–3500 AED |
Physician Insight & Safety Protocols
“This test for RB1 gene rearrangements is pivotal for assessing hereditary risk of retinoblastoma. A positive result mandates immediate ophthalmologic surveillance for children and genetic counseling for family members. A negative result does not rule out other types of mutations. Clinical correlation with family history and ophthalmological examination is essential.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠️ Medication Safety
Do not discontinue any prescribed medication without consulting your treating physician. Genetic testing does not substitute oncology or ophthalmology management.
Exclusion Criteria & Emergency Red Flags
- Exclusion: inability to provide informed consent; medically unstable for venipuncture (severe coagulopathy).
- Home collection may be deferred if phlebotomist identifies acute illness or difficult venous access.
- Emergency red flag: Leukocoria (white pupil reflex), strabismus, or sudden vision loss in a child – seek same‑day paediatric ophthalmology evaluation irrespective of genetic test booking.
Patient FAQ & Clinical Guidance
1. What is RB1 gene deletion/duplication testing and why is it done?
This test detects large missing or extra pieces of the RB1 gene to diagnose hereditary retinoblastoma or identify at‑risk family members. It is the gold standard for children presenting with bilateral eye tumours or a known family history.
2. How is the test performed and what is the turnaround time in the UAE?
A simple peripheral blood sample is collected via our home phlebotomy service or at a DHA‑licensed facility, with results delivered in 7–10 working days. The sample undergoes MLPA analysis in our ISO‑certified laboratory, and a comprehensive report is shared electronically.
3. Is a doctor’s prescription required, and can I use health insurance?
A valid DHA‑registered physician’s prescription is mandatory, except for surgery clearance, pregnancy screening, or international travel health certificates. Most UAE insurance plans cover genetic testing for retinoblastoma; our team verifies your coverage instantly via WhatsApp.
UAE Regulatory & Data Privacy Adherence
This service fully adheres to the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and the Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is processed locally in an ISO 9001:2015 certified facility (Cert: INT/EGQ/2509DA/3139) with end‑to‑end encryption. Doctor’s prescription is mandatory; contact our support line for exceptions.
Clinical & Logistical Metadata
| Test Name | RB1 Gene Deletion & Duplication Detection (Retinoblastoma) |
| Price (AED) | 1400 |
| Turnaround Time | 7–10 working days |
| Sample Type / Matrix | Peripheral whole blood |
| Methodology Used | Multiplex Ligation‑dependent Probe Amplification (MLPA) |
| ICD-10-CM Code | Z13.71 |
| LOINC Code | 68956-0 |
| DHA Facility License & Laboratory Address | License No: 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians